Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	protein localization to M-band	ANK2 OBSCN	1.88e-05	2	90	2	GO:0036309
GeneOntologyCellularComponent	NuA4 histone acetyltransferase complex	MEAF6 EPC2 BRD8	3.50e-04	32	90	3	GO:0035267
GeneOntologyCellularComponent	H4/H2A histone acetyltransferase complex	MEAF6 EPC2 BRD8	3.50e-04	32	90	3	GO:0043189
GeneOntologyCellularComponent	extracellular matrix	A1BG COL12A1 ADAMTS4 ADAMTS2 TNC VCAN MMP21 PODN SERAC1 MUC5AC	5.17e-04	656	90	10	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	A1BG COL12A1 ADAMTS4 ADAMTS2 TNC VCAN MMP21 PODN SERAC1 MUC5AC	5.30e-04	658	90	10	GO:0030312
GeneOntologyCellularComponent	mitotic spindle pole	STAG1 YPEL5 SPAG5	8.41e-04	43	90	3	GO:0097431
GeneOntologyCellularComponent	H4 histone acetyltransferase complex	MEAF6 EPC2 BRD8	9.61e-04	45	90	3	GO:1902562
GeneOntologyCellularComponent	perisynaptic extracellular matrix	TNC VCAN	9.83e-04	11	90	2	GO:0098966
MousePheno	embryonic lethality during organogenesis	SMG1 GTF2I CEP120 STAG1 IFT172 PIEZO1 VCAN TET1 RICTOR PTEN DENND1A CEP164 ZFX ZFY SNX13 DNMT3B	1.52e-05	876	76	16	MP:0006207
MousePheno	lethality during fetal growth through weaning, complete penetrance	SMG1 RANBP1 LLGL1 ANK2 STAG1 BCLAF1 IFT172 PIEZO1 IGHMBP2 MYT1 VCAN RICTOR GNAS HYDIN NLRP3 RYR1 ZFX ZFY DNMT3B	3.49e-05	1269	76	19	MP:0011111
MousePheno	abnormal embryonic growth/weight/body size	SMG1 RANBP1 GTF2I CSE1L STAG1 PRRC2C IFT172 PIEZO1 VCAN TET1 SUGP1 RICTOR PTEN DENND1A ZFX NDUFS8 ZFY SNX13 DNMT3B	4.62e-05	1295	76	19	MP:0002088
MousePheno	abnormal neural tube morphology	RANBP1 ZC3H11A LLGL1 PRRC2C IFT172 VCAN TET1 PTEN DENND1A CEP164 SNX13 DNMT3B	7.60e-05	591	76	12	MP:0002151
MousePheno	abnormal heart looping	SMG1 GTF2I CEP120 IFT172 VCAN CEP164	9.12e-05	135	76	6	MP:0000269
MousePheno	embryonic lethality during organogenesis, complete penetrance	SMG1 GTF2I CEP120 IFT172 VCAN TET1 RICTOR PTEN DENND1A CEP164 ZFX ZFY SNX13	9.16e-05	700	76	13	MP:0011098
MousePheno	abnormal extraembryonic tissue morphology	SMG1 RANBP1 GTF2I STAG1 IFT172 PIEZO1 VCAN TET1 RICTOR PTEN DENND1A ZFX ZFY SNX13 DNMT3B	9.30e-05	908	76	15	MP:0002086
MousePheno	abnormal prenatal growth/weight/body size	SMG1 RANBP1 GTF2I CSE1L STAG1 PRRC2C IFT172 PIEZO1 VCAN TET1 SUGP1 RICTOR PTEN DENND1A RYR1 ZFX NDUFS8 ZFY SNX13 DNMT3B	1.00e-04	1493	76	20	MP:0004196
MousePheno	postnatal lethality, complete penetrance	ANK2 BCLAF1 IGHMBP2 MYT1 GNAS HYDIN NLRP3 ZFX ZFY DNMT3B	1.41e-04	445	76	10	MP:0011085
MousePheno	abnormal neural tube closure	RANBP1 ZC3H11A PRRC2C IFT172 TET1 PTEN DENND1A SNX13 DNMT3B	2.02e-04	378	76	9	MP:0003720
MousePheno	decreased embryo size	SMG1 RANBP1 GTF2I CSE1L VCAN RICTOR PTEN ZFX NDUFS8 ZFY SNX13 DNMT3B	2.12e-04	659	76	12	MP:0001698
MousePheno	abnormal embryonic tissue morphology	RANBP1 ZC3H11A GTF2I CSE1L LLGL1 PRRC2C IFT172 PIEZO1 VCAN TET1 PTEN DENND1A CEP164 NDUFS8 SNX13 DNMT3B	2.72e-04	1116	76	16	MP:0002085
MousePheno	decreased skeletal muscle weight	COL12A1 IGHMBP2 RYR1	2.88e-04	24	76	3	MP:0010239
Domain	Zfx_Zfy_act	ZFX ZFY	6.72e-05	3	89	2	PF04704
Domain	Transcrp_activ_Zfx/Zfy-dom	ZFX ZFY	6.72e-05	3	89	2	IPR006794
Domain	ARM-type_fold	SMG1 CSE1L STAG1 NOC2L IFT172 NCAPD2 RICTOR SERAC1	2.14e-04	339	89	8	IPR016024
Domain	ARM-like	SMG1 CSE1L STAG1 NCAPD2 RICTOR SERAC1	1.84e-03	270	89	6	IPR011989
Domain	FCH	SRGAP1 TRIP10	4.87e-03	22	89	2	PF00611
Domain	FCH	SRGAP1 TRIP10	4.87e-03	22	89	2	SM00055
Pubmed	DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR.	RICTOR PTEN DNMT3B	6.69e-08	4	90	3	26923591
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MEAF6 DDX47 SMG1 RANBP1 SERBP1 GTF2I CSE1L NOC2L BCLAF1 PRRC2C NCAPD2 MRPS34 EIF3B GNAS DENND1A SPAG5 NDUFS8	1.50e-07	1440	90	17	30833792
Pubmed	Zfx facilitates tumorigenesis caused by activation of the Hedgehog pathway.	PTEN ZFX ZFY	1.67e-07	5	90	3	25164012
Pubmed	CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism.	MEAF6 EPC2 BRD8 EZHIP	3.58e-07	23	90	4	31281901
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	RANBP1 SERBP1 CSE1L UBE3A BCLAF1 PRRC2C ACO2 SUGP1 MRPS34 GNAS AKAP12	1.22e-06	665	90	11	30457570
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	ZC3H11A NOC2L BCLAF1 PIEZO1 NCAPD2 PRC1 SPAG5	1.29e-06	210	90	7	16565220
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	DDX47 SMG1 ZC3H11A SERBP1 ANK2 NOC2L PRRC2C YPEL5 MRPS34 EIF3B GNAS MAPK4 PRC1	1.30e-06	971	90	13	33306668
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	SMG1 SERBP1 CSE1L TNC BCLAF1 EIF3B HERC1 PTEN DOP1A	1.49e-06	420	90	9	28065597
Pubmed	Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis.	ZC3H11A SERBP1 GTF2I CSE1L BCLAF1 MRPS34 EIF3B	2.81e-06	236	90	7	36339263
Pubmed	Characterizing ZC3H18, a Multi-domain Protein at the Interface of RNA Production and Destruction Decisions.	MEAF6 DDX47 RANBP1 ZC3H11A GTF2I NOC2L BCLAF1 PRRC2C PPHLN1 EIF3B PRC1	3.03e-06	731	90	11	29298432
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	DDX47 RANBP1 ZC3H11A SERBP1 GTF2I CSE1L NOC2L BCLAF1 ACO2 NCAPD2 MRPS34 EIF3B GNAS PRC1 NDUFS8	3.65e-06	1425	90	15	30948266
Pubmed	Human transcription factor protein interaction networks.	MEAF6 SMG1 EPC2 RANBP1 BRD8 GTF2I CSE1L PRRC2C ACO2 SUGP1 ETV4 GON4L MRPS34 EIF3B HERC1	3.77e-06	1429	90	15	35140242
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	DDX47 ZC3H11A SERBP1 GTF2I CSE1L NOC2L BCLAF1 PRRC2C SRGAP1 MRPS34 PPHLN1 EIF3B GNAS PRC1	4.21e-06	1257	90	14	36526897
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	SMG1 ANK2 NOC2L ACO2 NCAPD2 SUGP1 AKAP12	6.31e-06	267	90	7	33417871
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ZC3H11A BRD8 SERBP1 NOC2L PIEZO1 IGHMBP2 NCAPD2 GON4L MRPS34 PPHLN1 RICTOR EIF3B DENND1A CEP164 NDUFS8	6.60e-06	1497	90	15	31527615
Pubmed	Involvement of tenascin-C and PG-M/versican in flexor tenosynovial pathology of idiopathic carpal tunnel syndrome.	TNC VCAN	6.62e-06	2	90	2	16493581
Pubmed	Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene.	ZFX ZFY	6.62e-06	2	90	2	1691708
Pubmed	The structure of the Zfx gene on the mouse X chromosome.	ZFX ZFY	6.62e-06	2	90	2	8188262
Pubmed	Mapping the human ZFX locus to Xp21.3 by in situ hybridization.	ZFX ZFY	6.62e-06	2	90	2	2497060
Pubmed	Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY.	ZFX ZFY	6.62e-06	2	90	2	2041734
Pubmed	Gene expression, X-inactivation, and methylation during spermatogenesis: the case of Zfa, Zfx, and Zfy in mice.	ZFX ZFY	6.62e-06	2	90	2	8318216
Pubmed	PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1.	LLGL1 PTEN	6.62e-06	2	90	2	23907540
Pubmed	[Expression of Zfx in mouse testicular spermatogenic cells].	ZFX ZFY	6.62e-06	2	90	2	38602753
Pubmed	Differential rates of evolution for the ZFY-related zinc finger genes, Zfy, Zfx, and Zfa in the mouse genus Mus.	ZFX ZFY	6.62e-06	2	90	2	12716983
Pubmed	Intron/exon structure confirms that mouse Zfy1 and Zfy2 are members of the ZFY gene family.	ZFX ZFY	6.62e-06	2	90	2	9126493
Pubmed	Evolution of the Zfx and Zfy genes: rates and interdependence between the genes.	ZFX ZFY	6.62e-06	2	90	2	8487630
Pubmed	Zfx mutation results in small animal size and reduced germ cell number in male and female mice.	ZFX ZFY	6.62e-06	2	90	2	9187153
Pubmed	Mapping of the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase (GNAS1) to 20q13.2----q13.3 in human by in situ hybridization.	CHGB GNAS	6.62e-06	2	90	2	1769666
Pubmed	Regional assignments of the zinc finger Y-linked gene (ZFY) and related sequences on human and mouse chromosomes.	ZFX ZFY	6.62e-06	2	90	2	2265557
Pubmed	TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.	TET1 PTEN	6.62e-06	2	90	2	27121319
Pubmed	Critical Role of ADAMTS-4 in the Development of Sporadic Aortic Aneurysm and Dissection in Mice.	ADAMTS4 VCAN	6.62e-06	2	90	2	28955046
Pubmed	Mouse Zfx protein is similar to Zfy-2: each contains an acidic activating domain and 13 zinc fingers.	ZFX ZFY	6.62e-06	2	90	2	2105457
Pubmed	p38δ MAPK: A Novel Regulator of NLRP3 Inflammasome Activation With Increased Expression in Coronary Atherogenesis.	MAPK13 NLRP3	6.62e-06	2	90	2	27417584
Pubmed	Transcription factor Zfx controls BCR-induced proliferation and survival of B lymphocytes.	ZFX ZFY	6.62e-06	2	90	2	19329779
Pubmed	CagA increases DNA methylation and decreases PTEN expression in human gastric cancer.	TET1 PTEN	6.62e-06	2	90	2	30431097
Pubmed	Chromosomal localization of ZFX--a human gene that escapes X inactivation--and its murine homologs.	ZFX ZFY	6.62e-06	2	90	2	1970799
Pubmed	RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking.	GNAS SNX13	6.62e-06	2	90	2	11729322
Pubmed	Comparison of human ZFY and ZFX transcripts.	ZFX ZFY	6.62e-06	2	90	2	2308929
Pubmed	RNAi as a tool to control the sex ratio of mouse offspring by interrupting Zfx/Zfy genes in the testis.	ZFX ZFY	6.62e-06	2	90	2	28251288
Pubmed	Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.	TNC VCAN	6.62e-06	2	90	2	15073129
Pubmed	Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.	ZFX ZFY	6.62e-06	2	90	2	34324278
Pubmed	From PTEN loss of expression to RICTOR role in smooth muscle differentiation: complex involvement of the mTOR pathway in leiomyosarcomas and pleomorphic sarcomas.	RICTOR PTEN	6.62e-06	2	90	2	22080063
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	RANBP1 BRD8 SERBP1 GTF2I CEP120 STAG1 BCLAF1 MRPS34 EIF3B GNAS PRC1 AKAP12 SPAG5	8.59e-06	1155	90	13	20360068
Pubmed	Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.	COL12A1 ADAMTS4 TNC VCAN	8.82e-06	50	90	4	23658023
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	DDX47 ZC3H11A BRD8 SERBP1 GTF2I CSE1L UBE3A BCLAF1 NCAPD2 PPHLN1 EIF3B PRC1	1.20e-05	1014	90	12	32416067
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	DDX47 ZC3H11A SERBP1 GTF2I NOC2L BCLAF1 MRPS34 PPHLN1 EIF3B TRIP10 ZFY	1.21e-05	847	90	11	35850772
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	RANBP1 ZC3H11A BRD8 SERBP1 GTF2I BCLAF1 PRRC2C TET1 NCAPD2	1.30e-05	549	90	9	38280479
Pubmed	The mammalian YL1 protein is a shared subunit of the TRRAP/TIP60 histone acetyltransferase and SRCAP complexes.	MEAF6 EPC2 BRD8	1.58e-05	19	90	3	15647280
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	DDX47 SMG1 GTF2I NOC2L BCLAF1 RICTOR PRC1 TRIP10	1.93e-05	440	90	8	34244565
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMG1 RANBP1 ANK2 STAG1 NOC2L BCLAF1 PRRC2C ACO2 NCAPD2 MMP21 CAGE1 ATP12A DOP1A DNMT3B	1.97e-05	1442	90	14	35575683
Pubmed	5-Methylcytosine and 5-Hydroxymethylcytosine in Scrapie-Infected Sheep and Mouse Brain Tissues.	TET1 DNMT3B	1.98e-05	3	90	2	36675131
Pubmed	Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN.	TNC PTEN	1.98e-05	3	90	2	19885556
Pubmed	Versican Proteolysis by ADAMTS Proteases and Its Influence on Sex Steroid Receptor Expression in Uterine Leiomyoma.	ADAMTS4 VCAN	1.98e-05	3	90	2	28323982
Pubmed	Characterization of the ZFX family of transcription factors that bind downstream of the start site of CpG island promoters.	ZFX ZFY	1.98e-05	3	90	2	32406922
Pubmed	Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN gene.	PTEN DNMT3B	1.98e-05	3	90	2	27223069
Pubmed	Blockade of ZFX Alleviates Hypoxia-Induced Pulmonary Vascular Remodeling by Regulating the YAP Signaling.	ZFX ZFY	1.98e-05	3	90	2	38310188
Pubmed	Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.	ANK2 OBSCN	1.98e-05	3	90	2	18782775
Pubmed	Inflammatory mediators ATP and S100A12 activate the NLRP3 inflammasome to induce MUC5AC production in airway epithelial cells.	MUC5AC NLRP3	1.98e-05	3	90	2	29906464
Pubmed	Differential Expression and Clinical Significance of DNA Methyltransferase 3B (DNMT3B), Phosphatase and Tensin Homolog (PTEN) and Human MutL Homologs 1 (hMLH1) in Endometrial Carcinomas.	PTEN DNMT3B	1.98e-05	3	90	2	28220037
Pubmed	Silencing of astrin induces the p53-dependent apoptosis by suppression of HPV18 E6 expression and sensitizes cells to paclitaxel treatment in HeLa cells.	UBE3A SPAG5	1.98e-05	3	90	2	16546135
Pubmed	mTORC2 Promotes Tumorigenesis via Lipid Synthesis.	RICTOR PTEN	1.98e-05	3	90	2	29232555
Pubmed	Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation.	GNAS PTEN	1.98e-05	3	90	2	35012940
Pubmed	Dietary glucosamine overcomes the defects in αβ-T cell ontogeny caused by the loss of de novo hexosamine biosynthesis.	RICTOR PTEN	1.98e-05	3	90	2	36456551
Pubmed	TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN/PI3K/AKT signaling pathway in acute myeloid leukemia cells.	TET1 PTEN	1.98e-05	3	90	2	36682704
Pubmed	Zfy gene expression patterns are not compatible with a primary role in mouse sex determination.	ZFX ZFY	1.98e-05	3	90	2	2480529
Pubmed	HOTAIR suppresses PTEN via DNMT3b and confers drug resistance in acute myeloid leukemia.	PTEN DNMT3B	1.98e-05	3	90	2	33538241
Pubmed	Genetic dissection of mammalian fertility pathways.	ZFX ZFY	1.98e-05	3	90	2	12479614
Pubmed	Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.	ANK2 OBSCN	1.98e-05	3	90	2	12527750
Pubmed	Identification and validation of mRNA 3'untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN.	PTEN DNMT3B	1.98e-05	3	90	2	31894272
Pubmed	X chromosome genes and premature ovarian failure.	ZFX ZFY	1.98e-05	3	90	2	11299520
Pubmed	Competitive binding of TET1 and DNMT3A/B cooperates the DNA methylation pattern in human embryonic stem cells.	TET1 DNMT3B	1.98e-05	3	90	2	35998875
Pubmed	PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.	PTEN AKAP12	1.98e-05	3	90	2	37875657
Pubmed	DNMT3B and TET1 mediated DNA methylation of LATS1 regulates BC progression via hippo signaling pathway.	TET1 DNMT3B	1.98e-05	3	90	2	36413827
Pubmed	Isolation of monochromosomal hybrids for mouse chromosomes 3, 6, 10, 12, 14, and 18.	ZFX ZFY	1.98e-05	3	90	2	9060403
Pubmed	Global Oct4 target gene analysis reveals novel downstream PTEN and TNC genes required for drug-resistance and metastasis in lung cancer.	TNC PTEN	1.98e-05	3	90	2	25609695
Pubmed	YAC clone contigs surrounding the Zfx and Pola loci on the mouse X chromosome.	ZFX ZFY	1.98e-05	3	90	2	8406471
Pubmed	Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4.	ADAMTS4 VCAN	1.98e-05	3	90	2	11278559
Pubmed	Foxo3a-Mediated DNMT3B Impedes Cervical Cancer Cell Proliferation and Migration Capacities through Suppressing PTEN Promoter Methylation.	PTEN DNMT3B	1.98e-05	3	90	2	36653180
Pubmed	Nephronophthisis-Related Ciliopathies	NPHP1 IFT172 CEP164	2.15e-05	21	90	3	27336129
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	ZC3H11A SERBP1 BCLAF1 PRRC2C MRPS34 EIF3B	2.58e-05	223	90	6	20020773
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	MEAF6 EPC2 ZC3H11A GTF2I SUGP1	2.66e-05	134	90	5	25452129
Pubmed	Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans.	MEAF6 EPC2 BRD8	2.86e-05	23	90	3	14966270
Pubmed	Myocardial Angiopoietin-1 Controls Atrial Chamber Morphogenesis by Spatiotemporal Degradation of Cardiac Jelly.	ADAMTS4 ADAMTS2 VCAN	3.26e-05	24	90	3	29791855
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	SERBP1 CSE1L ANK2 UBE3A BCLAF1 PRRC2C ACO2 IGHMBP2 SLC39A6 RICTOR EIF3B PTEN	3.75e-05	1139	90	12	36417873
Pubmed	RanBP1 is crucial for the release of RanGTP from importin beta-related nuclear transport factors.	RANBP1 CSE1L	3.96e-05	4	90	2	9428644
Pubmed	[DNA hypomethylation in villi of patients with unexplained recurrent spontaneous abortion and its mechanism].	TET1 DNMT3B	3.96e-05	4	90	2	31167695
Pubmed	E6-AP/UBE3A protein acts as a ubiquitin ligase toward SOX9 protein.	UBE3A HERC1	3.96e-05	4	90	2	24155239
Pubmed	Non-thermal dielectric-barrier discharge plasma induces reactive oxygen species by epigenetically modifying the expression of NADPH oxidase family genes in keratinocytes.	TET1 DNMT3B	3.96e-05	4	90	2	32863235
Pubmed	ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia.	ZFX ZFY	3.96e-05	4	90	2	24485662
Pubmed	Pre-B cell receptor-mediated activation of BCL6 induces pre-B cell quiescence through transcriptional repression of MYC.	BLNK PTEN	3.96e-05	4	90	2	21856866
Pubmed	mTORC1 Deficiency Prevents the Development of MC903-Induced Atopic Dermatitis through the Downregulation of Type 2 Inflammation.	RICTOR PTEN	3.96e-05	4	90	2	36983043
Pubmed	Amniotic fluid mesenchymal stem cells repair mouse corneal cold injury by promoting mRNA N4-acetylcytidine modification and ETV4/JUN/CCND2 signal axis activation.	ETV4 NLRP3	3.96e-05	4	90	2	33010000
Pubmed	Zfx controls the self-renewal of embryonic and hematopoietic stem cells.	ZFX ZFY	3.96e-05	4	90	2	17448993
Pubmed	Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses.	RICTOR PTEN	3.96e-05	4	90	2	25559258
Pubmed	Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency.	RICTOR PTEN	3.96e-05	4	90	2	31636454
Pubmed	Opposing Tumor-Promoting and -Suppressive Functions of Rictor/mTORC2 Signaling in Adult Glioma and Pediatric SHH Medulloblastoma.	RICTOR PTEN	3.96e-05	4	90	2	29996106
Pubmed	mTOR complex 1 plays critical roles in hematopoiesis and Pten-loss-evoked leukemogenesis.	RICTOR PTEN	3.96e-05	4	90	2	22958934
Pubmed	Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression.	RICTOR PTEN	3.96e-05	4	90	2	22958933
Pubmed	ADAMTS: a novel family of proteases with an ADAM protease domain and thrombospondin 1 repeats.	ADAMTS4 ADAMTS2	3.96e-05	4	90	2	10094461
Pubmed	Proteolytic cleavage of versican during limb joint development.	ADAMTS4 VCAN	3.96e-05	4	90	2	20101710
Interaction	HES6 interactions	NOC2L RICTOR HERC1 PTEN ACBD6	3.50e-06	52	90	5	int:HES6
GeneFamily	Granins	CHGB GNAS	3.30e-04	8	63	2	925
GeneFamily	Mitogen-activated protein kinases	MAPK4 MAPK13	9.09e-04	13	63	2	651
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS4 ADAMTS2	1.97e-03	19	63	2	50
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	SRGAP1 TRIP10	2.88e-03	23	63	2	1288
Coexpression	PEREZ_TP53_TARGETS	CEP120 LLGL1 TP53INP1 ADAMTS2 MYT1 VCAN LRRTM2 OBSCN BLNK ZNF398 GNAS MAPK13 MUC5AC CEP164 ZNF440 DOP1A DNMT3B	6.08e-07	1201	90	17	M4391
Coexpression	FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP	TNC PIEZO1 VCAN TRIP10 AKAP12	1.49e-05	90	90	5	M48360
Coexpression	DODD_NASOPHARYNGEAL_CARCINOMA_UP	DDX47 SMG1 RANBP1 ZC3H11A CSE1L ADAMTS2 UBE3A PRRC2C VCAN TET1 SLC39A6 EIF3B PRC1 PTEN DENND1A SPAG5	2.17e-05	1407	90	16	M14427
Coexpression	DAIRKEE_CANCER_PRONE_RESPONSE_BPA	RANBP1 CSE1L EIF3B PTEN	2.87e-05	51	90	4	M8655
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	SMG1 UBE3A BCLAF1 YPEL5 GON4L RICTOR GNAS ACBD6 ZFX	3.71e-05	474	90	9	M40991
Coexpression	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	DDX47 RANBP1 LLGL1 AKAP12 SPAG5	4.29e-05	112	90	5	M4939
Coexpression	MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	DDX47 RANBP1 LLGL1 AKAP12 SPAG5	4.86e-05	115	90	5	MM599
Coexpression	GSE3982_MAST_CELL_VS_TH1_UP	SLC39A6 GNAS HERC1 ATP12A MUC5AC DOP1A	6.51e-05	199	90	6	M5453
Coexpression	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	DDX47 GTF2I YPEL5 BLNK PRC1 CYTH4	6.51e-05	199	90	6	M3186
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	BRD8 TNC BCLAF1 PPHLN1 CAGE1 PRC1 PTEN SPAG5 ZFX	7.44e-05	519	90	9	M3395
CoexpressionAtlas	DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000	SMG1 UBE3A PRRC2C BLNK ETV4 MAPK4 PTEN MAPK13 RNF128 CEP164 ZFX SNX13 DNMT3B	2.50e-05	801	88	13	gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	COL12A1 ADAMTS2 TNC SRGAP1 VCAN ABCA10 AKAP12	1.28e-07	192	90	7	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 ADAMTS4 ADAMTS2 VCAN PODN ABCA10 AKAP12	1.69e-07	200	90	7	ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 ADAMTS2 SRGAP1 VCAN PODN ABCA10 AKAP12	1.69e-07	200	90	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL12A1 ANK2 ADAMTS2 VCAN PODN ABCA10 AKAP12	1.69e-07	200	90	7	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 ADAMTS2 SRGAP1 VCAN PODN ABCA10 AKAP12	1.69e-07	200	90	7	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 ADAMTS2 SRGAP1 VCAN PODN ABCA10 AKAP12	1.69e-07	200	90	7	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 ADAMTS2 SRGAP1 VCAN PODN ABCA10 AKAP12	1.69e-07	200	90	7	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 ADAMTS4 SRGAP1 VCAN PODN ABCA10 AKAP12	1.69e-07	200	90	7	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL12A1 ANK2 ADAMTS2 VCAN PODN ABCA10 AKAP12	1.69e-07	200	90	7	0c25d56292b9e5fefa4521b72635449be1ffd6fe
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SRGAP1 BLNK DENND1A NLRP3 RYR1 CYTH4	2.43e-06	190	90	6	f573fef3762a30c38cf8fa7f45df0ffbb49dc873
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ADAMTS2 SRGAP1 DENND1A NLRP3 RYR1 CYTH4	2.43e-06	190	90	6	2d54fca50593fbd11fe13fc2bfaf937a05db776d
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANK2 ADAMTS4 ADAMTS2 VCAN TRIP10 AKAP12	2.43e-06	190	90	6	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ANK2 ADAMTS2 VCAN PODN ABCA10 AKAP12	2.43e-06	190	90	6	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS2 VCAN PODN PTEN ABCA10	2.58e-06	192	90	6	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	COL12A1 ANK2 ADAMTS2 PODN ABCA10 AKAP12	2.58e-06	192	90	6	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	SMG1 BCLAF1 PRRC2C YPEL5 RICTOR GNAS	2.66e-06	193	90	6	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	COL12A1 ADAMTS2 TNC SRGAP1 VCAN ABCA10	2.74e-06	194	90	6	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	LA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	COL12A1 ADAMTS4 TNC VCAN ABCA10 AKAP12	2.74e-06	194	90	6	803fa83ceada17c38ca9f933b888f7e7b0b90761
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANK2 ADAMTS2 SRGAP1 PODN ABCA10 AKAP12	2.82e-06	195	90	6	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL12A1 ANK2 VCAN PODN ABCA10 AKAP12	2.82e-06	195	90	6	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	droplet-Bladder-nan-3m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 ADAMTS2 TNC VCAN PODN AKAP12	2.91e-06	196	90	6	f47e551ba484687ba6ce8c29a085106131364042
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	SMG1 BCLAF1 PRRC2C YPEL5 RICTOR GNAS	2.99e-06	197	90	6	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	SMG1 BCLAF1 PRRC2C YPEL5 RICTOR GNAS	3.08e-06	198	90	6	44417089b62056269cac38d3134ff209c05b7007
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	ANK2 ADAMTS2 SRGAP1 PODN ABCA10 AKAP12	3.08e-06	198	90	6	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LILRB3 SRGAP1 DENND1A NLRP3 RYR1 CYTH4	3.08e-06	198	90	6	c7dbf24caae5c4ef285845d13055de9e07281bb3
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	COL12A1 ADAMTS2 TNC VCAN PODN AKAP12	3.08e-06	198	90	6	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	ANK2 ADAMTS2 SRGAP1 VCAN PODN ABCA10	3.08e-06	198	90	6	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SMG1 BCLAF1 PRRC2C YPEL5 RICTOR GNAS	3.08e-06	198	90	6	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	GTF2I ANK2 BCLAF1 PRRC2C VCAN LRRTM2	3.08e-06	198	90	6	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DDX47 BRD8 CSE1L NCAPD2 PRC1 SPAG5	3.17e-06	199	90	6	c7c501ad144ac5488d0b0496554d46616f2e01a6
ToppCell	COVID-19-kidney-Fibroblast-1\|kidney / Disease (COVID-19 only), tissue and cell type	COL12A1 ADAMTS4 ADAMTS2 TNC VCAN AKAP12	3.17e-06	199	90	6	9503646ff1ad248181146ce767e9d12e882ec3bd
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LILRB3 SRGAP1 DENND1A NLRP3 RYR1 CYTH4	3.27e-06	200	90	6	179afc4bee7a2fd85a3b5dadf32544a63807c164
ToppCell	Bronchial-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL12A1 ANK2 ADAMTS2 PODN ABCA10 AKAP12	3.27e-06	200	90	6	5ea12e17f50fefbf5534e487af3392b2fa2d13ad
ToppCell	Children_(3_yrs)-Immune-monocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LILRB3 VCAN PTEN DENND1A NLRP3 CYTH4	3.27e-06	200	90	6	881ab995c90d75fd987d6e8f1f926a4bfcc4235f
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LILRB3 SRGAP1 DENND1A NLRP3 RYR1 CYTH4	3.27e-06	200	90	6	ad52b38df5c71f28829b04cd0e6b97f0f9f7610a
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL12A1 ANK2 ADAMTS2 TNC VCAN PODN	3.27e-06	200	90	6	4dbe21cb63569f28c7017cda065ea5ee00d7254e
ToppCell	Parenchyma_COVID-19-Stromal-TX-Fibroblasts-4\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	COL12A1 ANK2 ADAMTS2 TNC VCAN PODN	3.27e-06	200	90	6	bde938e5a18844fb8cc1d1be5a086809f7e2b97d
ToppCell	Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-4\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL12A1 ANK2 ADAMTS2 TNC VCAN PODN	3.27e-06	200	90	6	8256511b099c3eab8e33194f90c9ff354e7cfe8e
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL12A1 ANK2 ADAMTS2 PODN ABCA10 AKAP12	3.27e-06	200	90	6	b04831708fa20471a127b87e8db3728b6e729ce8
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL12A1 ANK2 ADAMTS2 VCAN PODN ABCA10	3.27e-06	200	90	6	74ad0ae592252060ee294d7483327d765a6ba1dd
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	SMG1 BCLAF1 PRRC2C YPEL5 RICTOR GNAS	3.27e-06	200	90	6	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	Tracheal-10x5prime-Stromal-Fibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL12A1 ANK2 ADAMTS2 VCAN PODN ABCA10	3.27e-06	200	90	6	7ba292c30d915e66ebc8026fa76492cedf64700e
ToppCell	Tracheal-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	COL12A1 ANK2 ADAMTS2 VCAN PODN AKAP12	3.27e-06	200	90	6	920e6036c0a9c0089d0d898673daf9dd9d7279fc
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast-FB-3\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	ADAMTS2 TNC MYT1 VCAN MUC5AC	8.69e-06	137	90	5	25b5370b63644351efddb8749ef174beca0581cd
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADAMTS4 ADAMTS2 PODN ACBD6 AKAP12	1.79e-05	159	90	5	7ed659163f45e0c4df4782997c0786900c8186c8
ToppCell	10x5'-Lung-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|Lung / Manually curated celltypes from each tissue	VCAN NCAPD2 PRC1 SPAG5 DNMT3B	2.26e-05	167	90	5	82739226347d74897be000f429b73543a031af96
ToppCell	10x5'-Lung-Hematopoietic_progenitors\|Lung / Manually curated celltypes from each tissue	VCAN NCAPD2 PRC1 SPAG5 DNMT3B	2.26e-05	167	90	5	dec18caf0475002d4ad3c7bc7fc3050cbc8e6bae
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS4 ADAMTS2 TNC AKAP12	2.46e-05	170	90	5	fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS4 ADAMTS2 TNC AKAP12	2.46e-05	170	90	5	03044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCell	356C-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CSE1L NCAPD2 PODN PRC1 SPAG5	2.53e-05	171	90	5	b113fbebb89056af0b9c775d2fb6552206a80467
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 VCAN PODN ABCA10 AKAP12	2.53e-05	171	90	5	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 TNC SRGAP1 MMP21 AKAP12	2.83e-05	175	90	5	910a075ccaf79de22338ecf321fa0a867f3d7d75
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TNC NCAPD2 PRC1 RYR1 SPAG5	2.83e-05	175	90	5	9142ed8ca2f1c0c518deb21988221406f62fe38c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 TNC SRGAP1 MMP21 AKAP12	2.83e-05	175	90	5	f0c2eb82e17e8aec2cfa5d83169178f409cc1abc
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANK2 TNC VCAN OBSCN AKAP12	2.99e-05	177	90	5	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6\|TCGA-Ovary / Sample_Type by Project: Shred V9	DRP2 ADAMTS4 ADAMTS2 VCAN PODN	3.07e-05	178	90	5	142879e9393e721f9b05a6bb46995c9d6d713c95
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS2 TNC VCAN PODN	3.32e-05	181	90	5	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS2 TNC VCAN PODN	3.32e-05	181	90	5	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRB3 NCAPD2 PRC1 MAPK13 SPAG5	3.41e-05	182	90	5	9025178ede571e3808d4657ad4892152f336c9b4
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRB3 NCAPD2 PRC1 MAPK13 SPAG5	3.41e-05	182	90	5	c075756cd4bb484ede1be2bcdb9eac60eab0573a
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ADAMTS2 VCAN PTEN MAPK13 CYTH4	3.59e-05	184	90	5	a902109b04a94770f5f6db5ddc372049f2921d38
ToppCell	5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL12A1 ANK2 ADAMTS2 PODN AKAP12	3.69e-05	185	90	5	9faa35ceb89ccd2979072286f063687c9f846ce3
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL14A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	COL12A1 ADAMTS2 PODN ABCA10 AKAP12	3.69e-05	185	90	5	506eee2c1b6e8acec3aa8b2c66868010006c4c14
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL12A1 ANK2 ADAMTS2 TNC SRGAP1	3.69e-05	185	90	5	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	Dendritic_Cells-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	A1BG BRD8 SRGAP1 VCAN PTEN	3.69e-05	185	90	5	952ded6830b5cabf64d153fc2e003e681e4370a2
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SRGAP1 BLNK DENND1A RYR1 CYTH4	3.69e-05	185	90	5	8207f9eff113eed429e961748c6b17d672a13b33
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	DDX47 SMG1 BCLAF1 RICTOR HERC1	3.98e-05	188	90	5	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	ANK2 VCAN PODN ABCA10 AKAP12	3.98e-05	188	90	5	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	LILRB3 VCAN DENND1A NLRP3 CYTH4	4.08e-05	189	90	5	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	Control-Myeloid-Transitioning_MDM\|Control / group, cell type (main and fine annotations)	LILRB3 SRGAP1 VCAN DENND1A NLRP3	4.19e-05	190	90	5	d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 ADAMTS2 TNC SRGAP1 VCAN	4.19e-05	190	90	5	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 TNC VCAN PODN CHGB	4.19e-05	190	90	5	7f6dafd5418764d67f6d5ec2153233b791910e81
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BLNK SLC39A6 MMP21 CHGB IQUB	4.19e-05	190	90	5	078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK2 ADAMTS4 SRGAP1 PODN AKAP12	4.29e-05	191	90	5	f5ce33af56178333730be308253943c54a0724cf
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAMTS4 ADAMTS2 TNC SRGAP1 VCAN	4.29e-05	191	90	5	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL12A1 ADAMTS2 TNC VCAN AKAP12	4.29e-05	191	90	5	4b50fdd310701251e64e16cd2d07ce03dbfd3e3e
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	ADAMTS2 TNC PODN ABCA10 AKAP12	4.29e-05	191	90	5	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS2 VCAN PTEN ABCA10	4.29e-05	191	90	5	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL12A1 ADAMTS2 TNC VCAN AKAP12	4.29e-05	191	90	5	75d2197076a9dfc868e8baf95bd4c5e44f438e3e
ToppCell	Brain_organoid\|World / Sample Type, Dataset, Time_group, and Cell type.	A1BG RANBP1 GTF2I NOC2L ACO2	4.29e-05	191	90	5	d93b280124b9888cd3f199d025bd6c7a1a709f2a
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	ADAMTS2 TNC PODN ABCA10 AKAP12	4.29e-05	191	90	5	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RANBP1 NCAPD2 ETV4 PRC1 SPAG5	4.29e-05	191	90	5	b978afe76754cc56e1672abca27be289bb56375b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS2 VCAN PTEN ABCA10	4.29e-05	191	90	5	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL12A1 ANK2 ADAMTS2 ABCA10 AKAP12	4.40e-05	192	90	5	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS2 VCAN PODN PTEN	4.40e-05	192	90	5	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 ADAMTS4 ADAMTS2 TNC SRGAP1	4.40e-05	192	90	5	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RANBP1 NCAPD2 ETV4 PRC1 SPAG5	4.40e-05	192	90	5	5ef79faddb433c09ff36660d8bf7a3af5a67bf1d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS4 ADAMTS2 TNC SRGAP1 AKAP12	4.40e-05	192	90	5	8b86db2ebe0199fee0e9800566a619a24bfdeed5
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK2 ADAMTS4 SRGAP1 PODN AKAP12	4.40e-05	192	90	5	a8b7c539dc3037071bf068f372e4215563e11de4
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 ADAMTS4 ADAMTS2 TNC SRGAP1	4.40e-05	192	90	5	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK2 ADAMTS4 SRGAP1 PODN AKAP12	4.40e-05	192	90	5	904c003c4f73b1dfc8243cee02aad2676c515e50
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS2 TNC VCAN PODN	4.51e-05	193	90	5	dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TNC ANKRD45 HYDIN IQUB ZNF440	4.51e-05	193	90	5	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	LA-14._Fibroblast_III\|LA / Chamber and Cluster_Paper	ADAMTS4 TNC VCAN ABCA10 AKAP12	4.51e-05	193	90	5	7426c291bac59e539c427bcaae18abc7d397d44e
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BLNK SLC39A6 CHGB ATP12A IQUB	4.51e-05	193	90	5	e7012f7b53971972299db34fa51ff51a4e4987fe
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS2 TNC VCAN PODN	4.51e-05	193	90	5	e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCell	facs-Bladder-nan-18m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 ADAMTS4 TNC VCAN PODN	4.62e-05	194	90	5	f4c9fc53ae31d58096906d9305b0b4082512a7e9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 VCAN PTEN ABCA10 AKAP12	4.62e-05	194	90	5	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	droplet-Bladder-Unstain-18m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 ADAMTS4 TNC VCAN PODN	4.62e-05	194	90	5	ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ADAMTS2 TNC VCAN AKAP12	4.62e-05	194	90	5	240d122dcb9dd1ab2867503ad85869853adcacae
Disease	Malignant neoplasm of breast	RANBP1 ZC3H11A LLGL1 ANK2 ACO2 OBSCN ETV4 SLC39A6 PPHLN1 PRC1 PTEN AKAP12 DOP1A DNMT3B	3.95e-06	1074	89	14	C0006142
Disease	Profound Mental Retardation	STAG1 GON4L GNAS PTEN ACBD6	6.52e-05	139	89	5	C0020796
Disease	Mental Retardation, Psychosocial	STAG1 GON4L GNAS PTEN ACBD6	6.52e-05	139	89	5	C0025363
Disease	Mental deficiency	STAG1 GON4L GNAS PTEN ACBD6	6.52e-05	139	89	5	C0917816
Disease	THYROID CANCER, NONMEDULLARY, 2	SRGAP1 PTEN	8.94e-05	5	89	2	C4225426
Disease	joint hypermobility measurement	COL12A1 PIEZO1 VCAN	1.36e-04	33	89	3	EFO_0007905
Disease	Mammary Carcinoma, Human	ZC3H11A LLGL1 ETV4 SLC39A6 PRC1 PTEN AKAP12 DNMT3B	1.90e-04	525	89	8	C4704874
Disease	Mammary Neoplasms, Human	ZC3H11A LLGL1 ETV4 SLC39A6 PRC1 PTEN AKAP12 DNMT3B	1.90e-04	525	89	8	C1257931
Disease	Mammary Neoplasms	ZC3H11A LLGL1 ETV4 SLC39A6 PRC1 PTEN AKAP12 DNMT3B	1.95e-04	527	89	8	C1458155
Disease	Breast Carcinoma	ZC3H11A LLGL1 ETV4 SLC39A6 PRC1 PTEN AKAP12 DNMT3B	2.25e-04	538	89	8	C0678222
Disease	Colorectal Carcinoma	CSE1L ANK2 KCNA10 OBSCN GNAS PTEN ABCA10 IQUB AKAP12	2.71e-04	702	89	9	C0009402
Disease	Nephronophthisis	NPHP1 IFT172	3.19e-04	9	89	2	cv:C0687120
Disease	Intellectual Disability	STAG1 OXR1 GON4L SERAC1 GNAS PTEN ACBD6	4.14e-04	447	89	7	C3714756
Disease	Polydactyly	CEP120 IFT172 PTEN CEP164	4.42e-04	117	89	4	C0152427
Disease	Jeune thoracic dystrophy	CEP120 IFT172	4.86e-04	11	89	2	C0265275
Disease	Renal dysplasia and retinal aplasia (disorder)	NPHP1 CEP164	5.82e-04	12	89	2	C0403553
Disease	Ischemic stroke, fibrinogen measurement	STAG1 NLRP3 SNX13	6.21e-04	55	89	3	EFO_0004623, HP_0002140
Disease	tea consumption measurement	MYT1 SUGP1 DENND1A SNX13	6.39e-04	129	89	4	EFO_0010091
Disease	Short Rib-Polydactyly Syndrome	CEP120 IFT172	6.87e-04	13	89	2	C0036996
Disease	Bardet-Biedl Syndrome	NPHP1 IFT172	6.87e-04	13	89	2	C0752166
Disease	fibrinogen measurement, factor VII measurement	STAG1 NLRP3 SNX13	7.26e-04	58	89	3	EFO_0004619, EFO_0004623
Disease	Saldino-Noonan Syndrome	CEP120 IFT172	8.00e-04	14	89	2	C0036069
Disease	Majewski Syndrome	CEP120 IFT172	8.00e-04	14	89	2	C0024507
Disease	fibrinogen measurement, coronary artery disease	STAG1 SUGP1 NLRP3 SNX13	1.23e-03	154	89	4	EFO_0001645, EFO_0004623
Disease	R-warfarin measurement	SMG1 ANK2 STAG1 ADAMTS2 CHGB	1.26e-03	265	89	5	EFO_0803324
Disease	myocardial infarction (biomarker_via_orthology)	RANBP1 TNC VCAN NLRP3	1.42e-03	160	89	4	DOID:5844 (biomarker_via_orthology)
Disease	polycystic kidney disease (biomarker_via_orthology)	TNC GNAS	1.49e-03	19	89	2	DOID:0080322 (biomarker_via_orthology)
Disease	epilepsy (implicated_via_orthology)	ANK2 KCNA10 UBE3A ATP12A	1.52e-03	163	89	4	DOID:1826 (implicated_via_orthology)
Disease	Headache, type 2 diabetes mellitus	GTF2I DENND1A	2.18e-03	23	89	2	HP_0002315, MONDO_0005148
Disease	Carcinoma of lung	RICTOR PTEN	2.18e-03	23	89	2	C0684249
Disease	Autism Spectrum Disorders	GTF2I TET1 DNMT3B	2.19e-03	85	89	3	C1510586
Disease	Dystonia	SLC19A3 SERAC1 PTEN	2.27e-03	86	89	3	C0013421
Disease	Intrahepatic Cholangiocarcinoma	GNAS PTEN	2.38e-03	24	89	2	C0345905
Disease	Extrahepatic Cholangiocarcinoma	GNAS PTEN	2.38e-03	24	89	2	C3805278
Disease	corneal resistance factor	STAG1 ADAMTS2 VCAN TET1 PPHLN1 ABCA10	2.46e-03	451	89	6	EFO_0010067
Disease	Cholangiocarcinoma	GNAS PTEN	2.79e-03	26	89	2	C0206698
Disease	multisite chronic pain	CEP120 STAG1 PRC1	3.01e-03	95	89	3	EFO_0010100

Protein segments in the cluster

Peptide	Gene	Start	Entry
DANPETHAFVTSPEI	ACO2	481	Q99798
EHDSPTEASQPIVEE	DDX47	6	Q9H0S4
HSSDEDEFPQVLSPV	EPC2	371	Q52LR7
PSFSDPEDFVDDVSE	EIF3B	151	P55884
SPSDPVHFEVDTSHE	CAGE1	11	Q8TC20
DIDTEVPSEPHDSND	VCAN	2596	P13611
NHVDESPVEFPATRS	DNMT3B	131	Q9UBC3
NEINPEHSSDDSFEP	ABCA10	366	Q8WWZ4
EHSSDDSFEPVSPEF	ABCA10	371	Q8WWZ4
EPPVSESDDGFSIHN	BRD8	661	Q9H0E9
DEESGEHTQVPADSP	AKAP12	541	Q02952
EHTQVPADSPDSQEE	AKAP12	546	Q02952
PPESESSEFFSQQEE	ANKRD45	6	Q5TZF3
SVSHENPTEVFEDGE	DOP1A	576	Q5JWR5
TENSPVTFAHFPEDT	ACSF2	411	Q96CM8
EPFSIPEDDGNDLTH	CYTH4	241	Q9UIA0
GEVEFPHSPEIEETS	ACBD6	26	Q9BR61
ATEDHPETNAVDEPY	ADAMTS2	1151	O95450
PDSDEQFVPDFHSEN	ETV4	71	P43268
ENTDESNHDPQFEPI	RANBP1	16	P43487
HETSEETEFPSEAPA	KASH5	406	Q8N6L0
VHSTRPEDEFDDPQA	LLGL1	346	Q15334
VPEAQEDVEATFPVH	A1BG	161	P04217
PVETEHSVPEDIFDT	ANK2	3521	Q01484
IQEPEEPSEHREESS	ANK2	3826	Q01484
EETPEGEEHHPVADT	SERBP1	256	Q8NC51
HSLSPEENEFAEEEP	PODN	36	Q7Z5L7
TTEEHFPEPDNAIFT	LRRTM2	406	O43300
EPTSQHPFRIEDEID	MAPK4	321	P31152
ESEPQPRSSEFTHEN	ATP12A	236	P54707
EEQAEIESTAHPATP	EZHIP	486	Q86X51
EEGFSESPDNLDHTE	HERC1	2846	Q15751
DDDEHFTPPTSDTGI	MMP21	261	Q8N119
EETEAQQPFDDSLEH	MAPK13	316	O15264
VELDSQSPHDEDPQA	LILRB3	526	O75022
QHSEEAEPEPSQEAE	MUC5AC	5626	P98088
DSSEEEEGPFHSLPD	NOC2L	101	Q9Y3T9
EPSVDFNHSDDFTPI	RICTOR	1136	Q6R327
DHSDFQDTDIPFEVP	IFT172	1616	Q9UG01
VEGPNFEFSTETHEE	NDUFS8	166	O00217
DDEPVHTSENAEVVF	OBSCN	4376	Q5VST9
EFDKTTNPDVHPTEA	OXR1	171	Q8N573
AEVDEPESHFSSIPD	KCNA10	396	Q16322
TPEDSDPDHFDTAIL	ADAMTS4	301	O75173
TEEVPEDEPAEVSAH	HYDIN	1536	Q4G0P3
PVEDNDENYIHPTES	BLNK	181	Q8WV28
AVHDEGESPPVTAQE	COL12A1	1636	Q99715
TDPVDHTDQPEFATE	CEP120	41	Q8N960
EPKDTFEHDPSESID	BCLAF1	186	Q9NYF8
PPQFVDIHLEEDDSS	GON4L	356	Q3T8J9
FPESPESESDHEHEE	GNAS	76	O95467
VPSEEPQESDQTEEH	IQUB	31	Q8NA54
PEEPITFCEEAFVSH	DENND1A	331	Q8TEH3
ESDTSPDFHNQENEP	MEAF6	121	Q9HAF1
TQHVPSETSEDPEVE	GTF2I	296	P78347
SENPDVSHPEEESNI	SLC19A3	476	Q9BZV2
PDFYDSEEPVSTHQE	CHGB	621	P05060
FEPPSEDLQHEEKQS	RYR1	451	P21817
DQPEEPESNTTHGIE	PPHLN1	266	Q8NEY8
SQHPFEELEEPHSES	DRP2	171	Q13474
SPDGVHEPFDLSEQT	NPHP1	706	O15259
DPENEPFDEDQHTQI	PTEN	386	P60484
PDDEHSEPVHTVVFQ	NLRP3	211	Q96P20
EEEAFTAFTPAPEDS	MRPS34	146	P82930
TLNHEDPTPEIFDDI	SNX13	471	Q9Y5W8
PFADPFSTVDIEDHE	SERAC1	116	Q96JX3
RFPTHPKESETEDQA	SPAG5	281	Q96R06
EEVDQDAGTEPHTSE	SRGAP1	726	Q7Z6B7
SHVASGESVDEDVPP	SMG1	376	Q96Q15
SELHVEPFQEEGETT	PRC1	81	O43663
DDHPEVTVIEDPQSN	PRRC2C	1661	Q9Y520
DVIPHVDNPTFEEDE	RNF128	401	Q8TEB7
PSHFDSQQPAVLEEE	SLC39A6	501	Q13433
ETVQPEVKSETEPHF	TET1	1806	Q8NFU7
VTVEENNASPHFEPD	CEP164	1046	Q9UPV0
DEDFEEEPTSPIGHC	TRIP10	531	Q15642
SEPFSHIDPEESEET	NCAPD2	546	Q15021
HRPSVFQSPDEDEEE	SUGP1	156	Q8IWZ8
DDSHCGETFTPVPDD	ZNF440	76	Q8IYI8
VRESEGFEEHVPSDN	YPEL5	106	P62699
FELPEDDTIPDEEHF	CSE1L	876	P55060
NHNEEDDEEPIPESS	UBE3A	391	Q05086
GHPATDLPTEEDFEA	IGHMBP2	871	P38935
EEDISEESPTEHPSV	TP53INP1	51	Q96A56
HNTEDQAGPEESEIP	ZNF398	201	Q8TD17
THPPVVINAADDDED	ZC3H11A	151	O75152
SEPSESFQEHTVDGE	TNC	81	P24821
DQIQEPESEHGSEPD	STAG1	1131	Q8WVM7
DSDITVHNFVPDDPD	ZFX	46	P17010
ESDQHVVPTAPDTEA	PIEZO1	366	Q92508
VDSDITVHNFVPDDP	ZFY	46	P08048
EDSHCGETFTPVPDD	ZNF439	91	Q8NDP4
REEEPEESEPAAHSF	MYT1	741	Q01538